HAVCR2 and cancer: Binding of Tim-3 with HMGB1 interfered with the recruitment of nucleic acids into DC endosomes, which lead to the attenuated therapeutic efficacy of DNA vaccination and chemotherapy by diminishing the immunogenicity of nucleic acids released from dying cancer cells (35).